In Canada, the Patented Medicine Prices Review Board examines drug pricing, compares the proposed Canadian price to that of seven other countries and determines if a price is “excessive” or not.
Foreign Policy | foreign policy | Office of Science and Technology Policy | public policy | policy | pharmaceutical industry | High Representative of the Union for Foreign Affairs and Security Policy | Pharmaceutical industry | Centre for Economic Policy Research | European Neighbourhood Policy | economic policy | Common Foreign and Security Policy | Policy Review | Pharmaceutical drug | pharmaceutical drug | Foreign Policy (magazine) | Canadian Centre for Policy Alternatives | social policy | Public Policy | Progressive Policy Institute | Policy | Pacific Council on International Policy | Office of Policy Coordination | Middle East Policy Council | Lee Kuan Yew School of Public Policy | Joan Shorenstein Center on the Press, Politics and Public Policy | Issam Fares Institute for Public Policy and International Affairs | Goldman School of Public Policy | Economic policy | Crawford School of Public Policy |